spacer
home > pmps > spring 2007 > changing clinical trials landscape
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Changing Clinical Trials Landscape

As trials become increasingly globalised, Chris Wilson of Keats Healthcare tells PMPS how bespoke supply solutions can bring down costs

Where do you see Keats Healthcare in five years’ time?

Although the clinical trials landscape is constantly evolving to meet the challenges of both pharma and regulatory authorities, I’m confident that Keats will be at the forefront of clinical trials comparator supply. As supply chains become ever more complex and critical, Keats will continue to service the needs of the global industry by adding value to clinical trial operations. There has been a lot of talk about escalating clinical trial costs, with the cost of bringing a product to market regularly put at over $US 1 billion. Most people know that this figure is manipulated, but it should be remembered that the adjustments are made to include not only the cost of molecules that fail in the early stages of testing, but also the huge cost to the industry of trials that collapse because of poor supplies – comparator availability is a huge part of that. What is certain is that with the increased prevalence of biologics and cold chain products in trials, companies need to have confidence in their comparator supply. The industry wants full pipelines, and is rightly looking to cut trial costs and durations, but we must be careful not to cut costs in the wrong places.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
After receiving an MA in Retail and Marketing from Manchester University, Chris Wilson began his career in the brewing and licensed retail industry with Carlsberg in Denmark, with roles including sales, procurement and marketing directorships. From there he was responsible for launching a leading branded wine with Pernod Ricard and spent a period as Head of Sales and Marketing at Sky TV. Chris joined Keats Healthcare Ltd as Managing Director, with a focus on providing clients with flexible and efficient clinical trial comparator supply solutions.
spacer
Chris Wilson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

High throughput, low energy consumption: AVENTUS to showcase high-performance packaging systems at interpack

• Joint venture for a broad range of solutions • Powerful and low-maintenance units for free-flowing bulk materials • Solutions for agriculture as well as the chemicals, salts, fertilisers pet food and animal feed industries
More info >>

White Papers

Bio/Pharmaceutical Methods: Do your Analytical Methods Hold Up to Regulatory Scrutiny?

Eurofins BioPharma Product Testing

As FDA guidelines evolve and drug products on the market begin to age, bio/pharmaceutical manufacturers face scrutiny of the original methods used to support these products. Therefore, manufacturers must re-evaluate these methods to ensure they comply with current FDA expectations. Some manufacturers are even facing consent decrees imposed by the agency requiring them to bring methods up to current standards within a specified timeframe. This exercise requires significant amounts of time and resources, which many manufacturers do not have since they are focused on getting their next products to market. For that reason, some clients have been turning to Eurofins Lancaster Laboratories for support.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement